4
Changes in Ownership
Dianthus Therapeutics, Inc. /DE/ Filed Acc 0001692444-26-000010
Options or other derivatives
- Director acquired 6,090 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Soteropoulos Paula Director | 2026-05-21 | Grant or award · Stock Option (Right to Buy) | +6,090 | 6,090 | D: show line 1 in the form |
Loading xslF345X06/ownership.xml…